Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
7.69
-0.16 (-2.04%)
At close: Jan 30, 2026, 4:00 PM EST
7.71
+0.02 (0.27%)
After-hours: Jan 30, 2026, 7:59 PM EST

Ardelyx Revenue

Ardelyx had revenue of $110.33M in the quarter ending September 30, 2025, with 12.30% growth. This brings the company's revenue in the last twelve months to $398.23M, up 58.12% year-over-year. In the year 2024, Ardelyx had annual revenue of $333.62M with 168.06% growth.

Revenue (ttm)
$398.23M
Revenue Growth
+58.12%
P/S Ratio
4.62
Revenue / Employee
$1,008,187
Employees
395
Market Cap
1.87B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024333.62M209.16M168.06%
Dec 31, 2023124.46M72.30M138.61%
Dec 31, 202252.16M42.06M416.57%
Dec 31, 202110.10M2.53M33.36%
Dec 31, 20207.57M2.29M43.36%
Dec 31, 20195.28M2.67M102.57%
Dec 31, 20182.61M-39.39M-93.79%
Dec 31, 201742.00M--
Dec 31, 2016---
Dec 31, 201524.03M-7.60M-24.02%
Dec 31, 201431.62M2.70M9.32%
Dec 31, 201328.93M23.52M434.71%
Dec 31, 20125.41M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Zai Lab441.63M
MannKind313.79M
Aurinia Pharmaceuticals265.81M
Vericel258.72M
Stoke Therapeutics205.63M
Syndax Pharmaceuticals111.30M
Ocular Therapeutix55.78M
Nuvation Bio26.75M
Revenue Rankings